Daniel Lliboutry Capdevila

Institutions of which they are part

Research technician
Headache and Neurological Pain

Vall Hebron Institut de Recerca

Daniel Lliboutry Capdevila

Institutions of which they are part

Research technician
Headache and Neurological Pain

Vall Hebron Institut de Recerca

Related news

Vall d'Hebron participates in demonstrating the first treatment against childhood migraine

The treatment with fremanezumab becomes the first approved therapy to demonstrate efficacy in children and adolescents, a key stage of life as it is one of the most disabling and concentrates the peak incidence of the disease.

The Vall d'Hebron Accredited Institute raises more than €8M in the ISCIII's AES 2025 calls

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

Equip del grup de Cefalea i Dolor Neurològic del VHIR

Early initiation of specific treatment for migraine improves the course of the disease

Two international studies led by Vall d'Hebron recommend early administration of specific drugs to prevent migraine to achieve a better response to therapy.